Cellular and molecular mechanisms for rapid regression of atherosclerosis: from bench top to potentially achievable

Kevin Jon Williams1, Jonathan E Feig, Edward A Fisher

  • 1Department of Medicine/Division of Endocrinology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Abstract

Insights

Atherosclerotic plaque regression is possible through improved arterial health, leading to reduced plaque buildup and better outcomes for vulnerable plaques. Enhanced lipid transport and reduced lipoprotein retention are key factors.

Area of Science:

  • Cardiovascular Research
  • Atherosclerosis Pathophysiology
  • Molecular Medicine

Background:

  • Decades of research confirm that atherosclerotic lesions, including advanced plaques, can undergo regression and remodeling.
  • Recent scientific advancements have elucidated the underlying mechanisms driving plaque regression.

Purpose of the Study:

  • To review recent insights into the mechanisms of atherosclerotic plaque regression and remodeling.
  • To highlight factors promoting plaque regression and their clinical implications.

Main Methods:

  • Review of existing literature on atherosclerotic lesion regression.
  • Analysis of molecular and cellular mechanisms involved in plaque regression.
  • Synthesis of findings related to lipid metabolism and cellular transport in atherosclerosis.

Main Results:

  • Plaque regression is promoted by reduced arterial retention of apolipoprotein B-lipoproteins and enhanced cholesterol efflux.
  • Foam cell emigration and subsequent removal of necrotic debris by phagocytes contribute significantly to plaque regression.
  • Cellular lipid efflux and foam cell emigration can be rapid following improvements in the plaque environment.

Conclusions:

  • Atherosclerotic plaque regression requires significant improvement in the plaque milieu, primarily through reduced atherogenic lipoproteins or enhanced reverse lipid transport.
  • Regression processes can rapidly correct features of vulnerable plaques associated with acute coronary syndromes.
  • New therapeutic strategies targeting lipoprotein levels and reverse lipid transport could establish plaque regression as a clinical objective.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Inflammation01:38

Inflammation

Overview
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...